BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29076043)

  • 1. Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal Metastases.
    Klaver CEL; van Huijgevoort NCM; de Buck van Overstraeten A; Wolthuis AM; Tanis PJ; van der Bilt JDW; Sagaert X; D'Hoore A
    Ann Surg Oncol; 2018 Jan; 25(1):212-220. PubMed ID: 29076043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for appendiceal and colorectal peritoneal metastases.
    Enblad M; Graf W; Birgisson H
    Eur J Surg Oncol; 2018 Jul; 44(7):997-1005. PubMed ID: 29576463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of metachronous peritoneal metastases in patients with pT4a versus pT4b colon cancer: An international multicentre cohort study.
    Bastiaenen VP; Aalbers AGJ; Arjona-Sánchez A; Bellato V; van der Bilt JDW; D'Hoore AD; Espinosa-Redondo E; Klaver CEL; Nagtegaal ID; van Ramshorst B; van Santvoort HC; Sica GS; Snaebjornsson P; Wasmann KATGM; de Wilt JHW; Wolthuis AM; Tanis PJ
    Eur J Surg Oncol; 2021 Sep; 47(9):2405-2413. PubMed ID: 34030920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of colorectal cancer patients at high risk of peritoneal metastases.
    Shariff U; Seretis C; Youssef H
    J BUON; 2015 May; 20 Suppl 1():S71-9. PubMed ID: 26051336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with extensive regional lymph node involvement (pN2) following potentially curative surgery for colorectal cancer are at increased risk for developing peritoneal metastases: a retrospective single-institution study.
    Bhatt A; Bhamre R; Rohila J; Kalikar V; Desouza A; Saklani A
    Colorectal Dis; 2019 Mar; 21(3):287-296. PubMed ID: 30457185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases.
    Baratti D; Kusamura S; Iusco D; Gimondi S; Pietrantonio F; Milione M; Guaglio M; Bonomi S; Grassi A; Virzì S; Leo E; Deraco M
    Ann Surg Oncol; 2017 Jan; 24(1):167-175. PubMed ID: 27519353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study.
    Lurvink RJ; Bakkers C; Rijken A; van Erning FN; Nienhuijs SW; Burger JW; Creemers GJ; Verhoef C; Lemmens VE; De Hingh IH
    Eur J Surg Oncol; 2021 May; 47(5):1026-1033. PubMed ID: 33272737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overall risk and risk factors for metachronous peritoneal metastasis after colorectal cancer surgery: a nationwide cohort study.
    Ravn S; Heide-Jørgensen U; Christiansen CF; Verwaal VJ; Hagemann-Madsen RH; Iversen LH
    BJS Open; 2020 Apr; 4(2):284-292. PubMed ID: 32207578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study.
    Razenberg LG; van Gestel YR; Lemmens VE; de Wilt JH; Creemers GJ; de Hingh IH
    Clin Colorectal Cancer; 2015 Dec; 14(4):e13-9. PubMed ID: 26140733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting recurrence and prognosis after R0 resection for colorectal cancer with peritoneal metastasis.
    Sato H; Maeda K; Kotake K; Sugihara K; Takahashi H
    J Gastroenterol; 2016 May; 51(5):465-72. PubMed ID: 26377391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of Peritoneal Metastasis in Stage IV Colorectal Cancer Patients With R0 Resection: A Multicenter, Retrospective Study.
    Arakawa K; Kawai K; Ishihara S; Hata K; Nozawa H; Oba K; Sugihara K; Watanabe T
    Dis Colon Rectum; 2017 Oct; 60(10):1041-1049. PubMed ID: 28891847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic predictions based on pathological findings of peritoneal dissemination in patients with stage IV colorectal cancer without residual disease (R0 status).
    Komori K; Kinoshita T; Oshiro T; Ouchi A; Ito S; Abe T; Senda Y; Misawa K; Ito Y; Natsume S; Higaki E; Okuno M; Hosoi T; An B; Hayashi D; Uchino T; Kunitomo A; Oki S; Takano J; Suenaga Y; Maeda S; Dei H; Numata Y; Shimizu Y
    Surg Today; 2019 Sep; 49(9):755-761. PubMed ID: 30963344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological Factors Associated with Recurrence and Prognosis after R0 Resection for Stage IV Colorectal Cancer with Peritoneal Metastasis.
    Sato H; Kotake K; Sugihara K; Takahashi H; Maeda K; Uyama I;
    Dig Surg; 2016; 33(5):382-91. PubMed ID: 27119565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Impact of Histologic Type in Curatively Resected Stage IV Colorectal Cancer: A Japanese Multicenter Retrospective Study.
    Shibata J; Kawai K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Sugihara K; Watanabe T
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S621-9. PubMed ID: 26350364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
    Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
    Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous lung ablation of pulmonary recurrence may improve survival in selected patients undergoing cytoreductive surgery for colorectal cancer with peritoneal carcinomatosis.
    Bin Traiki TA; Fisher OM; Valle SJ; Parikh RN; Kozman MA; Glenn D; Power M; Liauw W; Alzahrani NA; Morris DL
    Eur J Surg Oncol; 2017 Oct; 43(10):1939-1948. PubMed ID: 28888800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic features and cytologic techniques that aid pathologic stage assessment of colonic adenocarcinoma.
    Panarelli NC; Schreiner AM; Brandt SM; Shepherd NA; Yantiss RK
    Am J Surg Pathol; 2013 Aug; 37(8):1252-8. PubMed ID: 23774176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited effect of lymph node status on the metastatic pattern in colorectal cancer.
    Knijn N; van Erning FN; Overbeek LI; Punt CJ; Lemmens VE; Hugen N; Nagtegaal ID
    Oncotarget; 2016 May; 7(22):31699-707. PubMed ID: 27145371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study.
    Quere P; Facy O; Manfredi S; Jooste V; Faivre J; Lepage C; Bouvier AM
    Dis Colon Rectum; 2015 Aug; 58(8):743-52. PubMed ID: 26163953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intraperitoneal chemotherapy with mitomycin C on the prevention of peritoneal recurrence in colorectal cancer patients with positive peritoneal lavage cytology findings.
    Noura S; Ohue M; Shingai T; Kano S; Ohigashi H; Yano M; Ishikawa O; Takenaka A; Murata K; Kameyama M
    Ann Surg Oncol; 2011 Feb; 18(2):396-404. PubMed ID: 20839059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.